Drug Profile
XY 4083
Alternative Names: XY4083Latest Information Update: 03 Mar 2010
Price :
$50
*
At a glance
- Originator Xytis
- Class Nootropics
- Mechanism of Action Alpha7 nicotinic acetylcholine receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders